News & Awards
Recognition & impact
Recent news coverage of the lab and Dr. Kannan's research, awards, and discoveries.
AIMBE College of Fellows
Dr. Kannan was inducted into the 2026 Class of the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows, recognized for pioneering contributions in smart biomaterials for healthcare delivery.
National Academy of Inventors Fellow
Elected a 2025 Fellow of the National Academy of Inventors for creating nanoparticle-based drug delivery technologies with tangible impact on cancer treatment and patient outcomes.
Curators' Distinguished Professor
Named a Curators' Distinguished Professor — the University of Missouri's highest academic honor — recognizing outstanding contributions to cancer research, nanotechnology, and medical innovation.
Why lung cancer treatments stop working — and possible fixes
Lab researchers identified a molecular "seesaw" involving AXL and FN14 proteins that drives drug resistance in lung cancer, and developed a gelatin-based nanoparticle to co-silence both targets. Published in ACS Nano.